🇺🇸 FDA
Patent

US 10767179

MicroRNA composition for the treatment of neuroblastoma

granted A61KA61K31/713A61K45/06

Quick answer

US patent 10767179 (MicroRNA composition for the treatment of neuroblastoma) held by The Board of Regents of the University of Texas System expires Mon Sep 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Sep 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K31/713, A61K45/06